These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies. Al Omari MM; Zughul MB; Davies JE; Badwan AA J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440 [TBL] [Abstract][Full Text] [Related]
23. Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state. Sinha VR; Anitha R; Ghosh S; Nanda A; Kumria R J Pharm Sci; 2005 Mar; 94(3):676-87. PubMed ID: 15668949 [TBL] [Abstract][Full Text] [Related]
24. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924 [TBL] [Abstract][Full Text] [Related]
25. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization. Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961 [TBL] [Abstract][Full Text] [Related]
26. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex. Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265 [TBL] [Abstract][Full Text] [Related]
27. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution. Miyake K; Hirayama F; Uekama K J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700 [TBL] [Abstract][Full Text] [Related]
28. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative. Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach. Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636 [TBL] [Abstract][Full Text] [Related]
30. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. Jug M; Kosalec I; Maestrelli F; Mura P J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544 [TBL] [Abstract][Full Text] [Related]
31. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin. Corti G; Capasso G; Maestrelli F; Cirri M; Mura P J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867 [TBL] [Abstract][Full Text] [Related]
32. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin. Palmieri GF; Wehrlé P; Martelli S Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510 [TBL] [Abstract][Full Text] [Related]
33. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Ranpise NS; Kulkarni NS; Mair PD; Ranade AN Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225 [TBL] [Abstract][Full Text] [Related]
34. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies. Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393 [TBL] [Abstract][Full Text] [Related]
35. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin. Ozdemir N; Ordu S Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593 [TBL] [Abstract][Full Text] [Related]
36. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins. Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515 [TBL] [Abstract][Full Text] [Related]
37. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex]. Zhang YM; Li X; Sun CS; Chen CF Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450 [TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
39. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex. Patil AL; Pore YV; Kuchekar BS; Late SG Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387 [TBL] [Abstract][Full Text] [Related]
40. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state. Veiga MD; Ahsan F Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]